SCHEMBL1481997

SCHEMBL1481997

C[Si](C)(CCCn1nncc1-c1ccccc1)O[Si](C)(C)CCCn1nncc1-c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.51
CYP19A1 P11511 1/20 0.40
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C19 P33261 1/20 0.37
PTGS1 P23219 1/20 0.35
PTGS2 P35354 1/20 0.35
CDC7 O00311 1/20 0.34
HDAC3 O15379 2/20 0.34
HDAC2 Q92769 2/20 0.34
HDAC10 Q969S8 2/20 0.34
HDAC8 Q9BY41 2/20 0.34
HDAC6 Q9UBN7 2/20 0.34
TSHR P16473 1/20 0.34
DPP4 P27487 1/20 0.34
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CYP2D6 P10635 1/20 0.33
KCNJ6 P48051 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25402344 0.80 HDAC1 (0.57) HDAC1CYP1A2CYP2C19PTGS1PTGS2
SCHEMBL2899293 0.77 HDAC1 (0.60) HDAC1CYP1A2CYP3A4CYP2C19CDC7
SCHEMBL27432924 0.73 HDAC1 (0.56) HDAC1CYP19A1CYP1A2CYP3A4CYP2C19
SCHEMBL10153571 0.73 HDAC1 (0.52) HDAC1CYP19A1CYP1A2CYP3A4CYP2C19
SCHEMBL24011415 0.73 HDAC1 (0.48) HDAC1CYP19A1CYP1A2CYP3A4CYP2C19
SCHEMBL20592359 0.73 HDAC1 (0.49) HDAC1CYP19A1CYP1A2CYP3A4CYP2C19
SCHEMBL1482469 0.69 HDAC8 (0.52) HDAC1CYP19A1HDAC3HDAC2HDAC10
SCHEMBL2895467 0.68 CDC7 (0.61) HDAC1CYP19A1CDC7HDAC3HDAC2
SCHEMBL3320095 0.67 PTGS1 (0.46) HDAC1CYP1A2CYP3A4CYP2C19PTGS1
SCHEMBL2959419 0.67 HDAC1 (0.46) HDAC1CYP19A1CYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110077365-A1 PREPARATION OF ORGANOSILICON-CONTAINING TRIAZOLES MCMASTER UNIVERSITY (CA) 2011-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110077365-A1 PREPARATION OF ORGANOSILICON-CONTAINING TRIAZOLES ATR, RNF31, RNF5 HDAC1 3827/4885CYP19A1 1176/4885CYP1A2 516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.